Clinical Applications of Diabetes Antibody Testing

被引:194
作者
Bingley, Polly J. [1 ]
机构
[1] Southmead Hosp, Med Sch Unit, Dept Clin Sci N Bristol, Bristol BS10 5NB, Avon, England
关键词
GLUTAMIC-ACID DECARBOXYLASE; ISLET-CELL ANTIBODIES; INSULIN AUTOANTIBODIES; GENERAL-POPULATION; ADULTS LADA; STANDARDIZATION PROGRAM; INTERVENTION TRIAL; NATURAL-HISTORY; GAD ANTIBODIES; FOLLOW-UP;
D O I
10.1210/jc.2009-1365
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Autoantibodies to glutamate decarboxylase, islet antigen-2, insulin, and zinc transporter-8 are characteristic of type 1 diabetes. They are detectable before clinical onset and define the subgroup of patients with latent autoimmune diabetes in adults. Autoantibody assays are increasingly available to clinicians. This article reviews the prognostic significance of autoantibodies and considers the utility of diabetes antibody testing in routine clinical practice. Evidence Acquisition: The medical literature to May 2009 was reviewed for key articles and consensus statements covering use of islet autoantibody testing for prediction and classification of diabetes and implications for therapy. Evidence Synthesis: Sensitive and specific glutamate decarboxylase and islet antigen-2 antibody assays are widely available, although to insulin auto antibody assays remain variable. Islet autoantibodies appear early in life, and testing for multiple anti bodies identifies unaffected individuals at very high risk of type 1 diabetes with high sensitivity. This is important for research, but currently no intervention prevents or delays diabetes, and evidence of benefit from awareness of risk is weak. In non-insulin-treated diabetes, patients with autoantibodies progress to insulin requirement more rapidly, but evidence that testing benefits the individual patient is limited. Antibody testing is useful in classifying diabetes of other types. Conclusions: Islet autoantibody testing allows prediction of type 1 diabetes and definition of the latent autoimmune diabetes in adults subgroup of non-insulin-treated patients. Although useful for research, until therapies modulating the disease process become available, the benefit to individual patients is generally questionable. With a few exceptions, diabetes antibody testing does not yet have a role in routine clinical care. (J Clin Endocrinol Metab 95: 25-33, 2010)
引用
收藏
页码:25 / 33
页数:9
相关论文
共 92 条
[51]   Zinc Transporter 8 Antibodies Complement GAD and IA-2 Antibodies in the Identification and Characterization of Adult-Onset Autoimmune Diabetes Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4 [J].
Lampasona, Vito ;
Petrone, Antonio ;
Tiberti, Claudio ;
Capizzi, Marco ;
Spoletini, Marialuisa ;
di Pietro, Sergio ;
Songini, Marco ;
Bonicchio, Sara ;
Giorgino, Francesco ;
Bonifacio, Ezio ;
Bosi, Emanuele ;
Buzzetti, Raffaella .
DIABETES CARE, 2010, 33 (01) :104-108
[52]   The Deutsche Nicotinamide Intervention Study - An attempt to prevent type 1 diabetes [J].
Lampeter, EF ;
Klinghammer, A ;
Scherbaum, WA ;
Heinze, E ;
Haastert, B ;
Giani, G ;
Kolb, H .
DIABETES, 1998, 47 (06) :980-984
[53]   Increasing incidence of diabetes after gestational diabetes [J].
Lauenborg, J ;
Hansen, T ;
Jensen, DM ;
Vestergaard, H ;
Molsted-Prdersen, L ;
Hornnes, P ;
Locht, H ;
Pedersen, O ;
Damm, P .
DIABETES CARE, 2004, 27 (05) :1194-1199
[54]  
LENDRUM R, 1975, LANCET, V1, P880
[55]  
Li X, 2003, CHINESE MED J-PEKING, V116, P1728
[56]   Predictors of postpartum diabetes in women with gestational diabetes mellitus [J].
Löbner, K ;
Knopff, A ;
Baumgarten, A ;
Mollenhauer, U ;
Marienfeld, S ;
Garrido-Franco, M ;
Bonifacio, E ;
Ziegler, AG .
DIABETES, 2006, 55 (03) :792-797
[57]   Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA) [J].
Lohmann, T ;
Kellner, K ;
Verlohren, HJ ;
Krug, J ;
Steindorf, J ;
Scherbaum, WA ;
Seissler, J .
DIABETOLOGIA, 2001, 44 (08) :1005-1010
[58]   GAD treatment and insulin secretion in recent-onset type 1 diabetes [J].
Ludvigsson, Johnny ;
Faresjo, Maria ;
Hjorth, Maria ;
Axelsson, Stina ;
Cheramy, Mikael ;
Pihl, Mikael ;
Vaarala, Outi ;
Forsander, Gun ;
Ivarsson, Sten ;
Johansson, Calle ;
Lindh, Agne ;
Nilsson, Nils-Osten ;
Aman, Jan ;
Ortqvist, Eva ;
Zerhouni, Peter ;
Casas, Rosaura .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (18) :1909-1920
[59]   Insulin intervention in slowly progressive insulin-dependent (type 1) diabetes mellitus [J].
Maruyama, Taro ;
Tanaka, Shoichiro ;
Shimada, Akira ;
Funae, Osamu ;
Kasuga, Akira ;
Kanatsuka, Azuma ;
Takei, Izumi ;
Yamada, Satoru ;
Harii, Norikazu ;
Shimura, Hiroki ;
Kobayashi, Tetsuro .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (06) :2115-2121
[60]   Anti-thyroid peroxidase antibody, IA-2 antibody, and fasting C-peptide levels predict beta cell failure An patients with latent autoimmune diabetes An adults (LADA) - A 5-year follow-up of the Ehime study [J].
Murao, Satoshi ;
Kondo, Shiori ;
Ohashi, Jun ;
Fujii, Yasuhisa ;
Shimizu, Ikki ;
Fujiyama, Masao ;
Ohno, Keizo ;
Takada, Yasuharu ;
Nakai, Kazuaki ;
Yamane, Yukio ;
Osawa, Haruhiko ;
Makino, Hideichi .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 80 (01) :114-121